ANIP (STOCKS)
ANI Pharmaceuticals, Inc.
$78.310000
-0.050000 (-0.06%)
Prev close: $78.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Nikhil Lalwani
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,756.10M
- Employees
- 897
- P/E (TTM)
- 23.57
- P/B (TTM)
- 3.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $883.37M |
| Benefits Costs and Expenses | $787.58M |
| Costs And Expenses | $772.27M |
| Operating Expenses | $772.27M |
| Selling, General, and Administrative Expenses | $317.75M |
| Depreciation and Amortization | $91.42M |
| Research and Development | $51.66M |
| Other Operating Expenses | $311.45M |
| Operating Income/Loss | $111.09M |
| Income/Loss From Continuing Operations After Tax | $78.34M |
| Income/Loss From Continuing Operations Before Tax | $95.79M |
| Income Tax Expense/Benefit | $17.45M |
| Income Tax Expense/Benefit, Current | $2.69M |
| Income Tax Expense/Benefit, Deferred | $11.79M |
| Interest And Dividend Income, Operating | $12.50M |
| Net Income/Loss | $78.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $78.34M |
| Net Income/Loss Available To Common Stockholders, Basic | $77.18M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $8.12M |
| Preferred Stock Dividends And Other Adjustments | $1.16M |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $6.96M |
| Basic Earnings Per Share | $3.50 |
| Diluted Earnings Per Share | $3.32 |
| Basic Average Shares | 20,053,000 |
| Diluted Average Shares | 21,228,000 |
| Assets | $1.44B |
| Current Assets | $753.12M |
| Inventory | $143.07M |
| Prepaid Expenses | $23.19M |
| Other Current Assets | $586.86M |
| Noncurrent Assets | $687.26M |
| Fixed Assets | $62.48M |
| Intangible Assets | $479.53M |
| Other Non-current Assets | $145.26M |
| Liabilities | $899.65M |
| Current Liabilities | $278.11M |
| Accounts Payable | $62.58M |
| Wages | $37.90M |
| Other Current Liabilities | $177.63M |
| Noncurrent Liabilities | $621.54M |
| Equity | $540.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $540.72M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $1.44B |
| Net Cash Flow From Operating Activities | $185.23M |
| Net Cash Flow From Operating Activities, Continuing | $185.23M |
| Net Cash Flow From Investing Activities | -$34.32M |
| Net Cash Flow From Investing Activities, Continuing | -$34.32M |
| Net Cash Flow From Financing Activities | -$9.94M |
| Net Cash Flow From Financing Activities, Continuing | -$9.94M |
| Exchange Gains/Losses | -$233.00K |
| Net Cash Flow | $140.73M |
| Net Cash Flow, Continuing | $140.96M |
| Comprehensive Income/Loss | $74.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $74.03M |
| Other Comprehensive Income/Loss | -$4.31M |